Seeking Alpha

Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug...

Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug didn't meet targets in a late-stage Phase III trial. Despite the miss, the firms say the FDA granted a priority review to examine the proposed treatment for colon cancer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs